semaglutide elisa cross-reactivity glp-1 Mouse GLP-1R Reporter Assay Kit GLP-1-directed NMDA receptor antagonism for

Since more people are taking supplements, it is important to ask questions about their safety and effectiveness

(5:23) The metabolic, cardiovascular, and psoriatic disease convergence

Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes

For instance, in June 2024, a recent study by the National Library of Medicine, Secular Trends in Diabetes in India (STRiDE-I), revealed a concerning rise in type 2 diabetes (T2DM) prevalence among younger individuals (ages 2039) in southern India

Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia ( via central mechanisms ( Similarly, SGLT-2is, also referred to as gliflozins, represent another class of anti-hyperglycemic agents currently used in T2D treatment with favorable effects on body weight

Originally developed for diabetes, its now widely used for reducing appetite and promoting steady weight reduction